MedPage Today on MSN
Photodynamic therapy for the most common skin cancer wins approval
Approach for superficial basal cell carcinoma may be ideal for cosmetically sensitive loca ...
Aminolevulinic acid hydrochloride in combination with photodynamic therapy has been approved for the treatment of BCC.
Ameluz used in conjunction with the RhodoLED lamp becomes the first and only photodynamic therapy approved in the United ...
The FDA has approved aminolevulinic acid (ALA) hydrochloride topical gel, 10% (Ameluz), in combination with photodynamic ...
Medicus Pharma (NASDAQ:MDCX) said a completed Phase 2 study of its SkinJect therapy showed all 90 enrolled patients finished treatment without discontinuations, data the company says will guide its ...
Amazon S3 on MSN
Famous faces who have been diagnosed with skin cancer
Several public figures are using their platforms to raise awareness about skin cancer prevention and early detection, sharing ...
Basal cell carcinoma is the most common skin cancer, often caused by UV exposure, and originates in the epidermis's basal cells. Diagnosis involves clinical examination and biopsy to confirm BCC and ...
The FDA has approved aminolevulinic acid hydrochloride 10% (Ameluz) in combination with photodynamic therapy for treating ...
A topical fluorescent molecular contrast agent, PARPi-FL, can detect basal cell carcinoma through intact skin in as little as five minutes in ex vivo human tissues, according to new preclinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results